RNA, U1 small nuclear 70, pseudogeneGenealiases: []
Q-omics provides the consensus-scored RNU1-70P profile across patient tissues and cancer cell-line models. RNU1-70P expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, RNU1-70P is differentially expressed in 12, with the highest sampling consensus in KIRC. Additionally, RNU1-70P RNA expression shows 13,830 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight KIRC, and THYM as cancer lineages where RNU1-70P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RNU1-70P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RNU1-70P survival associations across molecular data types. RNU1-70P RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RNU1-70P RNA expression–survival associations across cancer types. High RNU1-70P expression shows unfavorable associations in COAD, LAML and UCEC, but favorable associations in KIRC, LIHC and UVM. The KIRC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for RNU1-70P RNA expression.
This table summarizes RNU1-70P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for RNU1-70P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RNU1-70P shows lower tumor expression in KICH, BRCA and CHOL and higher tumor expression in KIRC, BLCA and LUSC. The KIRC box plot shows higher RNU1-70P RNA expression in tumor versus normal tissue (log2 FC = +1.869, t-test p < 0.001).
This table shows molecular features associated with RNU1-70P in patient tissues and cancer cell lines. In patient samples, RNU1-70P shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
